[Podcast] The Power of Persistence: From Biotech Incubator to Product Launch
1 min read
Welcome to “The Power of Persistence: From Biotech Incubator to First Product Launch,” a three-episode podcast series featuring seasoned experts who share valuable insights and tips about bringing biotech products to market. In this series, we delve into the journey of BioLineRx, a biopharmaceutical company founded in Israel, from its inception as a biotech incubator to achieving FDA approval for its first product, motixafortide.
Check out the podcast episode below.
Ep. 1
From Incubation to Laser-Focused Biotech Innovation
In the inaugural episode, we explore the origins of BioLineRx and its transformation from a biotech incubator to a fully-fledged biotech company. Joined by Phil Serlin, CEO of BioLineRx, we uncover the company’s early days, its broad pipeline spanning various therapeutic areas, and the strategic decision-making process that led to its evolution. From strategic evaluations to pivoting towards oncology and hematology, this episode highlights the importance of persistence and strategic adaptability in the biotech industry.
